Search

everythinglearnresearchcommunity

for

Search:↓

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride helps with prostate symptoms but may cause sexual side effects.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Finasteride can cause melasma, especially in people with darker skin.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Finasteride can cause melasma, especially in people with darker skin.

Finasteride can cause melasma, especially in people with darker skin.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

The document suggests that drugs for prostate issues might cause lasting sexual, mental, and physical health problems due to blood vessel damage in the penis.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Finasteride does not negatively affect male reproductive function.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.